Discontinued — last reported Q1 '26
Merck & Co. Animal Health — Other Nonoperating Income (Expense) increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$1.00M to $0.00.
Significant non-operating expenses can drag down segment margins, while income can provide a temporary boost to net results.
Financial gains or losses that fall outside the core operating activities of the animal health segment, such as interest...
Standard non-operating line item found in segment-level income statements.
mrk_segment_animal_health_other_nonoperating_income_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $250.00K | $250.00K | $250.00K | $250.00K | $1.00M | $1.00M | $1.00M | -$4.00M | -$1.00M | $0.00 | -$1.00M | $0.00 |
| QoQ Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | +300.0% | +0.0% | +0.0% | -500.0% | +75.0% | +100.0% | — | +100.0% |
| YoY Change | — | — | — | — | — | — | — | — | +300.0% | +300.0% | +300.0% | <-999% | -200.0% | -100.0% | -200.0% | +100.0% |